nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—Diclofenac—Clonidine—glaucoma	0.488	1	CrCrCtD
Lumiracoxib—PTGS2—glaucoma	0.268	1	CbGaD
Lumiracoxib—CYP1A2—Betaxolol—glaucoma	0.041	0.188	CbGbCtD
Lumiracoxib—CYP2C19—Methazolamide—glaucoma	0.0337	0.155	CbGbCtD
Lumiracoxib—CYP2C9—Diclofenamide—glaucoma	0.0325	0.149	CbGbCtD
Lumiracoxib—CYP2C9—Dorzolamide—glaucoma	0.0314	0.144	CbGbCtD
Lumiracoxib—CYP2C19—Timolol—glaucoma	0.0286	0.132	CbGbCtD
Lumiracoxib—CYP2C9—Methazolamide—glaucoma	0.028	0.129	CbGbCtD
Lumiracoxib—CYP1A2—Clonidine—glaucoma	0.0224	0.103	CbGbCtD
Lumiracoxib—Bromfenac—PTGS2—glaucoma	0.000682	0.311	CrCbGaD
Lumiracoxib—Tolmetin—PTGS2—glaucoma	0.000459	0.209	CrCbGaD
Lumiracoxib—Meclofenamic acid—PTGS2—glaucoma	0.000452	0.206	CrCbGaD
Lumiracoxib—Mefenamic acid—PTGS2—glaucoma	0.000352	0.16	CrCbGaD
Lumiracoxib—Diclofenac—PTGS2—glaucoma	0.000253	0.115	CrCbGaD
Lumiracoxib—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000181	0.00757	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000172	0.00721	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—TXN—glaucoma	0.000171	0.00715	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—TXN—glaucoma	0.000166	0.00694	CbGpPWpGaD
Lumiracoxib—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000165	0.00691	CbGpPWpGaD
Lumiracoxib—PTGS1—Eicosanoid Synthesis—PTGS2—glaucoma	0.000165	0.00688	CbGpPWpGaD
Lumiracoxib—PTGS2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000161	0.00674	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—SLC6A1—glaucoma	0.000153	0.00638	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—C1QB—glaucoma	0.000147	0.00616	CbGpPWpGaD
Lumiracoxib—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	0.000147	0.00612	CbGpPWpGaD
Lumiracoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000145	0.00608	CbGpPWpGaD
Lumiracoxib—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000143	0.00595	CbGpPWpGaD
Lumiracoxib—PTGS1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000142	0.00595	CbGpPWpGaD
Lumiracoxib—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000141	0.0059	CbGpPWpGaD
Lumiracoxib—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000138	0.00576	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—TNF—glaucoma	0.000134	0.0056	CbGpPWpGaD
Lumiracoxib—UGT1A9—PPARA activates gene expression—ABCA1—glaucoma	0.000133	0.00554	CbGpPWpGaD
Lumiracoxib—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.00013	0.00543	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—ABCA1—glaucoma	0.000129	0.0054	CbGpPWpGaD
Lumiracoxib—UGT1A9—Phase II conjugation—GSTM1—glaucoma	0.000127	0.0053	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—TGFB2—glaucoma	0.000124	0.0052	CbGpPWpGaD
Lumiracoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000124	0.00519	CbGpPWpGaD
Lumiracoxib—PTGS2—S1P1 pathway—VEGFA—glaucoma	0.000124	0.00519	CbGpPWpGaD
Lumiracoxib—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	0.000119	0.00498	CbGpPWpGaD
Lumiracoxib—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000117	0.0049	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—GSTT1—glaucoma	0.000116	0.00487	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—SOD1—glaucoma	0.000115	0.00482	CbGpPWpGaD
Lumiracoxib—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000114	0.00477	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000114	0.00475	CbGpPWpGaD
Lumiracoxib—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000107	0.00446	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—TNF—glaucoma	0.000106	0.00445	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—ABCA1—glaucoma	0.000103	0.00429	CbGpPWpGaD
Lumiracoxib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000101	0.00423	CbGpPWpGaD
Lumiracoxib—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	9.99e-05	0.00418	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	9.76e-05	0.00408	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	9.76e-05	0.00408	CbGpPWpGaD
Lumiracoxib—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	9.76e-05	0.00408	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—GSTT1—glaucoma	9.49e-05	0.00397	CbGpPWpGaD
Lumiracoxib—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	9.29e-05	0.00388	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—CYP1B1—glaucoma	9.28e-05	0.00388	CbGpPWpGaD
Lumiracoxib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	9.23e-05	0.00386	CbGpPWpGaD
Lumiracoxib—PTGS1—Arachidonic acid metabolism—PTGS2—glaucoma	9.16e-05	0.00383	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metapathway biotransformation—CYP1B1—glaucoma	9.15e-05	0.00382	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	9.15e-05	0.00382	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—MTHFR—glaucoma	9.14e-05	0.00382	CbGpPWpGaD
Lumiracoxib—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	9.13e-05	0.00381	CbGpPWpGaD
Lumiracoxib—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	9.11e-05	0.00381	CbGpPWpGaD
Lumiracoxib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	8.95e-05	0.00374	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	8.67e-05	0.00362	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	8.52e-05	0.00356	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—GSTM1—glaucoma	8.46e-05	0.00353	CbGpPWpGaD
Lumiracoxib—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.21e-05	0.00343	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NARFL—glaucoma	8.16e-05	0.00341	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CA5A—glaucoma	8.16e-05	0.00341	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	8.11e-05	0.00339	CbGpPWpGaD
Lumiracoxib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.89e-05	0.0033	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—NGFR—glaucoma	7.81e-05	0.00326	CbGpPWpGaD
Lumiracoxib—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.79e-05	0.00325	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—CYP1B1—glaucoma	7.56e-05	0.00316	CbGpPWpGaD
Lumiracoxib—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.49e-05	0.00313	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—GSTM1—glaucoma	7.42e-05	0.0031	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	7.36e-05	0.00308	CbGpPWpGaD
Lumiracoxib—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	7.32e-05	0.00306	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metapathway biotransformation—GSTM1—glaucoma	7.32e-05	0.00306	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase II conjugation—GSTT1—glaucoma	7.29e-05	0.00305	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	7.25e-05	0.00303	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	7.07e-05	0.00295	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—BDNF—glaucoma	6.8e-05	0.00284	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	6.77e-05	0.00283	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CA5A—glaucoma	6.65e-05	0.00278	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NARFL—glaucoma	6.65e-05	0.00278	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL1A—glaucoma	6.53e-05	0.00273	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.4e-05	0.00267	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	6.12e-05	0.00256	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—GSTM1—glaucoma	6.05e-05	0.00253	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—PTGS2—glaucoma	5.83e-05	0.00243	CbGpPWpGaD
Lumiracoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	5.76e-05	0.00241	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.61e-05	0.00234	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—GSTT1—glaucoma	5.47e-05	0.00229	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NARFL—glaucoma	5.28e-05	0.00221	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CA5A—glaucoma	5.28e-05	0.00221	CbGpPWpGaD
Lumiracoxib—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	5.28e-05	0.00221	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	5.25e-05	0.00219	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	5.13e-05	0.00215	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	5.05e-05	0.00211	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—GSTT1—glaucoma	4.99e-05	0.00209	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	4.91e-05	0.00205	CbGpPWpGaD
Lumiracoxib—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	4.82e-05	0.00201	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—LRP12—glaucoma	4.78e-05	0.002	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	4.65e-05	0.00194	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase II conjugation—GSTM1—glaucoma	4.64e-05	0.00194	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	4.62e-05	0.00193	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	4.55e-05	0.0019	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	4.4e-05	0.00184	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—CYP1B1—glaucoma	4.36e-05	0.00182	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	4.3e-05	0.0018	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—GSTT1—glaucoma	4.26e-05	0.00178	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	4.17e-05	0.00174	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	4.17e-05	0.00174	CbGpPWpGaD
Lumiracoxib—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	4.11e-05	0.00172	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.07e-05	0.0017	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CA1—glaucoma	3.99e-05	0.00167	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—CYP1B1—glaucoma	3.98e-05	0.00166	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	3.96e-05	0.00165	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	3.93e-05	0.00164	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	3.92e-05	0.00164	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CTSA—glaucoma	3.86e-05	0.00161	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NARFL—glaucoma	3.84e-05	0.0016	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CA5A—glaucoma	3.84e-05	0.0016	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.71e-05	0.00155	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CA2—glaucoma	3.65e-05	0.00152	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.56e-05	0.00149	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.56e-05	0.00149	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CA5A—glaucoma	3.5e-05	0.00146	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NARFL—glaucoma	3.5e-05	0.00146	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—GSTM1—glaucoma	3.49e-05	0.00146	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	3.46e-05	0.00145	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	3.46e-05	0.00145	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	3.44e-05	0.00144	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—CYP1B1—glaucoma	3.4e-05	0.00142	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	3.38e-05	0.00141	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	3.35e-05	0.0014	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CA1—glaucoma	3.25e-05	0.00136	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MMP9—glaucoma	3.21e-05	0.00134	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—GSTM1—glaucoma	3.18e-05	0.00133	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.17e-05	0.00133	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CTSA—glaucoma	3.15e-05	0.00131	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	3.14e-05	0.00131	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	3.12e-05	0.0013	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FGFR1OP—glaucoma	3.08e-05	0.00129	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HEYL—glaucoma	3.08e-05	0.00129	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CA5A—glaucoma	2.99e-05	0.00125	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NARFL—glaucoma	2.99e-05	0.00125	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CA2—glaucoma	2.97e-05	0.00124	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	2.97e-05	0.00124	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	2.97e-05	0.00124	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.9e-05	0.00121	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.9e-05	0.00121	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—GSTM1—glaucoma	2.72e-05	0.00114	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	2.68e-05	0.00112	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CA1—glaucoma	2.58e-05	0.00108	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—TXN—glaucoma	2.57e-05	0.00107	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CTSA—glaucoma	2.5e-05	0.00104	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TNF—glaucoma	2.47e-05	0.00103	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CA2—glaucoma	2.36e-05	0.000986	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.36e-05	0.000985	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.34e-05	0.000979	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.32e-05	0.00097	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.31e-05	0.000963	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.31e-05	0.000963	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TP53—glaucoma	2.18e-05	0.00091	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—TXN—glaucoma	2.09e-05	0.000875	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GSTT1—glaucoma	1.99e-05	0.000832	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.96e-05	0.000819	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HDAC9—glaucoma	1.92e-05	0.000803	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.91e-05	0.000798	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.89e-05	0.000791	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CA1—glaucoma	1.87e-05	0.000783	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CTSA—glaucoma	1.81e-05	0.000758	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CA2—glaucoma	1.71e-05	0.000716	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CA1—glaucoma	1.71e-05	0.000714	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.68e-05	0.000702	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.67e-05	0.0007	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.67e-05	0.0007	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—TXN—glaucoma	1.66e-05	0.000694	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CTSA—glaucoma	1.65e-05	0.000691	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTT1—glaucoma	1.62e-05	0.000678	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.61e-05	0.000671	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ABCA1—glaucoma	1.59e-05	0.000663	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CYP1B1—glaucoma	1.59e-05	0.000663	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CA2—glaucoma	1.56e-05	0.000653	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.53e-05	0.000638	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.53e-05	0.000638	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.52e-05	0.000634	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.5e-05	0.000628	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.48e-05	0.000619	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CA1—glaucoma	1.46e-05	0.00061	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CTSA—glaucoma	1.41e-05	0.000591	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CA2—glaucoma	1.34e-05	0.000558	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.31e-05	0.000547	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.3e-05	0.000545	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.3e-05	0.000545	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP1B1—glaucoma	1.29e-05	0.00054	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ABCA1—glaucoma	1.29e-05	0.00054	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTT1—glaucoma	1.29e-05	0.000538	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GSTM1—glaucoma	1.27e-05	0.00053	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—TXN—glaucoma	1.21e-05	0.000504	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—MTHFR—glaucoma	1.12e-05	0.000468	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.1e-05	0.00046	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—TXN—glaucoma	1.1e-05	0.00046	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.09e-05	0.000456	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—APOE—glaucoma	1.04e-05	0.000436	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTM1—glaucoma	1.03e-05	0.000432	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CAV1—glaucoma	1.03e-05	0.000432	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN2B—glaucoma	1.03e-05	0.000432	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ABCA1—glaucoma	1.03e-05	0.000429	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP1B1—glaucoma	1.03e-05	0.000429	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1e-05	0.00042	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.95e-06	0.000416	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—TXN—glaucoma	9.41e-06	0.000393	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTT1—glaucoma	9.36e-06	0.000391	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—MTHFR—glaucoma	9.14e-06	0.000382	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MTHFR—glaucoma	8.66e-06	0.000362	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.58e-06	0.000359	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTT1—glaucoma	8.53e-06	0.000357	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—APOE—glaucoma	8.51e-06	0.000355	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.5e-06	0.000355	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CAV1—glaucoma	8.43e-06	0.000352	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTM1—glaucoma	8.21e-06	0.000343	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—APOE—glaucoma	8.07e-06	0.000337	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CAV1—glaucoma	7.99e-06	0.000334	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NOS3—glaucoma	7.82e-06	0.000327	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.55e-06	0.000315	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—BAD—glaucoma	7.52e-06	0.000314	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ABCA1—glaucoma	7.46e-06	0.000312	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP1B1—glaucoma	7.46e-06	0.000312	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTT1—glaucoma	7.29e-06	0.000305	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—MTHFR—glaucoma	7.26e-06	0.000303	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGS2—glaucoma	7.15e-06	0.000299	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.88e-06	0.000288	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ABCA1—glaucoma	6.8e-06	0.000284	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP1B1—glaucoma	6.8e-06	0.000284	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—APOE—glaucoma	6.75e-06	0.000282	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CAV1—glaucoma	6.69e-06	0.00028	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NOS3—glaucoma	6.37e-06	0.000266	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOS3—glaucoma	6.04e-06	0.000252	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTM1—glaucoma	5.96e-06	0.000249	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.88e-06	0.000246	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTGS2—glaucoma	5.83e-06	0.000244	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP1B1—glaucoma	5.81e-06	0.000243	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ABCA1—glaucoma	5.81e-06	0.000243	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTM1—glaucoma	5.44e-06	0.000227	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—MTHFR—glaucoma	5.27e-06	0.00022	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN1B—glaucoma	5.23e-06	0.000219	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NOS3—glaucoma	5.06e-06	0.000211	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—APOE—glaucoma	4.91e-06	0.000205	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CAV1—glaucoma	4.86e-06	0.000203	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MTHFR—glaucoma	4.8e-06	0.000201	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTM1—glaucoma	4.65e-06	0.000194	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—APOE—glaucoma	4.47e-06	0.000187	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CAV1—glaucoma	4.43e-06	0.000185	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MTHFR—glaucoma	4.11e-06	0.000172	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—APOE—glaucoma	3.82e-06	0.00016	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CAV1—glaucoma	3.79e-06	0.000158	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NOS3—glaucoma	3.68e-06	0.000154	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGS2—glaucoma	3.36e-06	0.00014	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NOS3—glaucoma	3.35e-06	0.00014	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS2—glaucoma	3.06e-06	0.000128	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NOS3—glaucoma	2.86e-06	0.00012	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS2—glaucoma	2.62e-06	0.000109	CbGpPWpGaD
